0001209191-16-121774.txt : 20160519
0001209191-16-121774.hdr.sgml : 20160519
20160519172142
ACCESSION NUMBER: 0001209191-16-121774
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160517
FILED AS OF DATE: 20160519
DATE AS OF CHANGE: 20160519
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVACARE CORP
CENTRAL INDEX KEY: 0000742112
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 952680965
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
BUSINESS PHONE: 4403296000
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaPorte Dale C
CENTRAL INDEX KEY: 0001314132
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15103
FILM NUMBER: 161664028
MAIL ADDRESS:
STREET 1: 1400 MCDONALD INVESTMENT CENTER
STREET 2: 800 SUPERIOR AVENUE
CITY: CLEVELAND
STATE: OH
ZIP: 44114
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-05-17
0
0000742112
INVACARE CORP
IVC
0001314132
LaPorte Dale C
ONE INVACARE WAY
ELYRIA
OH
44035
1
0
0
0
Common Shares
2016-05-17
4
S
0
375
10.33
D
35697
D
Common Shares
20000
I
By Trust
Stock Option (Right to Buy)
Common Shares
7858
7858
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of covering tax obligations arising in connection with the vesting of restricted shares.
Includes an aggregate of 9,932 restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan.
Owned by the Reporting Person's Rollover IRA.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
The reporting person holds previously reported options to buy 7,858 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted on February 12, 2009, at an exercise price of $19.09 per share, will expire on February 12, 2019, and became exercisable between March 31, 2010 and March 31, 2013.
/s/ Dale C. LaPorte, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated February 11, 2005, on file with the Commission
2016-05-19